SEARCH

SEARCH BY CITATION

References

  • 1
    Ljunggren, H. G. and Malmberg, K. J., Prospects for the use of NK cells in immunotherapy of human cancer. Nat. Rev. Immunol. 2007. 7: 329339.
  • 2
    Vivier, E., Tomasello, E., Baratin, M., Walzer, T. and Ugolini, S., Functions of natural killer cells. Nat. Immunol. 2008. 9: 503510.
  • 3
    Bryceson, Y. T., March, M. E., Ljunggren, H. G. and Long, E. O., Activation, coactivation, and costimulation of resting human natural killer cells. Immunol. Rev. 2006. 214: 7391.
  • 4
    Bryceson, Y. T., Chiang, S. C., Darmanin, S., Fauriat, C., Schlums, H., Theorell, J. and Wood, S. M., Molecular mechanisms of natural killer cell activation. J. Innate Immun. 2011. 3: 216226.
  • 5
    Moretta, A., Vitale, M., Bottino, C., Orengo, A. M., Morelli, L., Augugliaro, R., Barbaresi, M. et al., P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J. Exp. Med. 1993. 178: 597604.
  • 6
    Houchins, J. P., Lanier, L. L., Niemi, E. C., Phillips, J. H. and Ryan, J. C., Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C. J. Immunol. 1997. 158: 36033609.
  • 7
    Hoglund, P. and Brodin, P., Current perspectives of natural killer cell education by MHC class I molecules. Nat.Rev. Immunol. 2010. 10: 724734.
  • 8
    Andersson, S., Fauriat, C., Malmberg, J. A., Ljunggren, H. G. and Malmberg, K. J., KIR acquisition probabilities are independent of self-HLA class I ligands and increase with cellular KIR expression. Blood 2009. 114: 95104.
  • 9
    Uhrberg, M., Valiante, N. M., Shum, B. P., Shilling, H. G., Lienert-Weidenbach, K., Corliss, B., Tyan, D. et al., Human diversity in killer cell inhibitory receptor genes. Immunity 1997. 7: 753763.
  • 10
    Beziat, V., Descours, B., Parizot, C., Debre, P. and Vieillard, V., NK cell terminal differentiation: correlated stepwise decrease of NKG2A and acquisition of KIRs. PLoS One 2010. 5: e11966.
  • 11
    Bjorkstrom, N. K., Riese, P., Heuts, F., Andersson, S., Fauriat, C., Ivarsson, M. A., Bjorklund, A. T. et al., Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood 2010. 116: 38533864.
  • 12
    Lazetic, S., Chang, C., Houchins, J. P., Lanier, L. L. and Phillips, J. H., Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J. Immunol. 1996. 157: 47414745.
  • 13
    Braud, V. M., Allan, D. S., O'Callaghan, C. A., Soderstrom, K., D'Andrea, A., Ogg, G. S., Lazetic, S. et al., HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998. 391: 795799.
  • 14
    Aldrich, C. J., DeCloux, A., Woods, A. S., Cotter, R. J., Soloski, M. J. and Forman, J., Identification of a Tap-dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigen. Cell 1994. 79: 649658.
  • 15
    Borrego, F., Ulbrecht, M., Weiss, E. H., Coligan, J. E. and Brooks, A. G., Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J. Exp. Med. 1998. 187: 813818.
  • 16
    Guma, M., Angulo, A., Vilches, C., Gomez-Lozano, N., Malats, N. and Lopez-Botet, M., Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 2004. 104: 36643671.
  • 17
    Guma, M., Budt, M., Saez, A., Brckalo, T., Hengel, H., Angulo, A. and Lopez-Botet, M., Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts. Blood 2006. 107: 36243631.
  • 18
    Guma, M., Cabrera, C., Erkizia, I., Bofill, M., Clotet, B., Ruiz, L. and Lopez-Botet, M., Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients. J. Infect. Dis. 2006. 194: 3841.
  • 19
    Bjorkstrom, N. K., Lindgren, T., Stoltz, M., Fauriat, C., Braun, M., Evander, M., Michaelsson, J. et al., Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J. Exp. Med. 2011. 208: 1321.
  • 20
    Ahlenstiel, G., Titerence, R. H., Koh, C., Edlich, B., Feld, J. J., Rotman, Y., Ghany, M. G. et al., Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner. Gastroenterology 2010. 138: 325335.
  • 21
    Oliviero, B., Varchetta, S., Paudice, E., Michelone, G., Zaramella, M., Mavilio, D., De Filippi, F. et al., Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. Gastroenterology 2009. 137: 11511160.
  • 22
    Brunetta, E., Fogli, M., Varchetta, S., Bozzo, L., Hudspeth, K. L., Marcenaro, E., Moretta, A. et al., Chronic HIV-1 viremia reverses NKG2A/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection. AIDS 2009. 24: 2734.
  • 23
    Lopez-Verges, S., Milush, J. M., Schwartz, B. S., Pando, M. J., Jarjoura, J., York, V. A., Houchins, J. P. et al., Expansion of a unique CD57+NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc. Natl. Acad. Sci. USA 2011. 108: 1472514732.
  • 24
    Bayram, A., Ozkur, A. and Erkilic, S., Prevalence of human cytomegalovirus co-infection in patients with chronic viral hepatitis B and C: a comparison of clinical and histological aspects. J. Clin. Virol. 2009. 45: 212217.
  • 25
    Varani, S., Lazzarotto, T., Margotti, M., Masi, L., Gramantieri, L., Bolondi, L. and Landini, M. P., Laboratory signs of acute or recent cytomegalovirus infection are common in cirrhosis of the liver. J. Med. Virol. 2000. 62: 2528.
  • 26
    Litjens, N. H., de Wit, E. A. and Betjes, M. G., Differential effects of age, cytomegalovirus-seropositivity and end-stage renal disease (ESRD) on circulating T lymphocyte subsets. Immunity Ageing: I & A 2011. 8: 2.
  • 27
    Ljungman, P. and Brandan, R., Factors influencing cytomegalovirus seropositivity in stem cell transplant patients and donors. Haematologica 2007. 92: 11391142.
  • 28
    Nelson, P. K., Mathers, B. M., Cowie, B., Hagan, H., Des Jarlais, D., Horyniak, D. and Degenhardt, L., Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet 2011. 378: 571583.
  • 29
    Yawata, M., Yawata, N., Draghi, M., Partheniou, F., Little, A. M. and Parham, P., MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response. Blood 2008. 112: 23692380.
  • 30
    Cooley, S., Xiao, F., Pitt, M., Gleason, M., McCullar, V., Bergemann, T. L., McQueen, K. L. et al., A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immature. Blood 2007. 110: 578586.
  • 31
    Lopez-Verges, S., Milush, J. M., Pandey, S., York, V. A., Arakawa-Hoyt, J., Pircher, H., Norris, P. J. et al., CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset. Blood 2010. 116: 38653874.
  • 32
    Dunn, C., Brunetto, M., Reynolds, G., Christophides, T., Kennedy, P. T., Lampertico, P., Das, A. et al., Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J. Exp. Med. 2007. 204: 667680.
  • 33
    Moesta, A. K., Norman, P. J., Yawata, M., Yawata, N., Gleimer, M. and Parham, P., Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3. J. Immunol. 2008. 180: 39693979.
  • 34
    Foley, B. A., De Santis, D., Van Beelen, E., Lathbury, L. J., Christiansen, F. T. and Witt, C. S., The reactivity of Bw4+ HLA-B and HLA-A alleles with KIR3DL1: implications for patient and donor suitability for haploidentical stem cell transplantations. Blood 2008. 112: 435443.
  • 35
    Thananchai, H., Gillespie, G., Martin, M. P., Bashirova, A., Yawata, N., Yawata, M., Easterbrook, P. et al., Cutting Edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B. J. Immunol. 2007. 178: 3337.
  • 36
    Yu, J., Mao, H. C., Wei, M., Hughes, T., Zhang, J., Park, I. K., Liu, S. et al., CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets. Blood 2010. 115: 274281.
  • 37
    Juelke, K., Killig, M., Luetke-Eversloh, M., Parente, E., Gruen, J., Morandi, B., Ferlazzo, G. et al., CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells. Blood 2010. 116: 12991307.
  • 38
    Fadda, L., Borhis, G., Ahmed, P., Cheent, K., Pageon, S. V., Cazaly, A., Stathopoulos, S. et al., Peptide antagonism as a mechanism for NK cell activation. Proc. Natl. Acad. Sci. USA 2010. 107: 1016010165.
  • 39
    Peruzzi, M., Wagtmann, N. and Long, E. O., A p70 killer cell inhibitory receptor specific for several HLA-B allotypes discriminates among peptides bound to HLA-B*2705. J. Exp. Med. 1996. 184: 15851590.
  • 40
    Colantonio, A. D., Bimber, B. N., NeidermyerJr., W. J., Reeves, R. K., Alter, G., Altfeld, M., Johnson, R. P. et al., KIR polymorphisms modulate peptide-dependent binding to an MHC class I ligand with a Bw6 motif. PLoS Pathog. 2011. 7: e1001316.
  • 41
    Orr, M. T., Murphy, W. J. and Lanier, L. L., ‘Unlicensed’ natural killer cells dominate the response to cytomegalovirus infection. Nat. Immunol. 2010. 11: 321327.
  • 42
    Tomasec, P., Braud, V. M., Rickards, C., Powell, M. B., McSharry, B. P., Gadola, S., Cerundolo, V. et al., Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 2000. 287: 1031.
  • 43
    Ploegh, H. L., Viral strategies of immune evasion. Science 1998. 280: 248253.
  • 44
    Brodin, P., Karre, K. and Hoglund, P., NK cell education: not an on-off switch but a tunable rheostat. Trends Immunol. 2009. 30: 143149.
  • 45
    Sun, J. C. and Lanier, L. L., NK cell development, homeostasis and function: parallels with CD8(+) T cells. Nat. Rev. Immunol. 2011. 11: 645657.
  • 46
    Kuijpers, T. W., Baars, P. A., Dantin, C., van den Burg, M., van Lier, R. A. and Roosnek, E., Human NK cells can control CMV infection in the absence of T cells. Blood 2008. 112: 914915.
  • 47
    Sinzger, C., Bissinger, A. L., Viebahn, R., Oettle, H., Radke, C., Schmidt, C. A. and Jahn, G., Hepatocytes are permissive for human cytomegalovirus infection in human liver cell culture and In vivo. J. Infect. Dis. 1999. 180: 976986.
  • 48
    Takehara, T., Hayashi, N., Katayama, K., Ueda, K., Towata, T., Kasahara, A., Fusamoto, H. et al., Enhanced expression of HLA class I by inhibited replication of hepatitis B virus. J. Hepatol. 1992. 14: 232236.
  • 49
    Chen, Y., Cheng, M. and Tian, Z., Hepatitis B virus down-regulates expressions of MHC class I molecules on hepatoplastoma cell line. Cell. Mol. Immunol. 2006. 3: 373378.
  • 50
    Fukusato, T., Gerber, M. A., Thung, S. N., Ferrone, S. and Schaffner, F., Expression of HLA class I antigens on hepatocytes in liver disease. Am. J. Pathol. 1986. 123: 264270.
  • 51
    Herzer, K., Falk, C. S., Encke, J., Eichhorst, S. T., Ulsenheimer, A., Seliger, B. and Krammer, P. H., Upregulation of major histocompatibility complex class I on liver cells by hepatitis C virus core protein via p53 and TAP1 impairs natural killer cell cytotoxicity. J. Virol. 2003. 77: 82998309.
  • 52
    Nattermann, J., Nischalke, H. D., Hofmeister, V., Ahlenstiel, G., Zimmermann, H., Leifeld, L., Weiss, E. H. et al., The HLA-A2 restricted T cell epitope HCV core 35-44 stabilizes HLA-E expression and inhibits cytolysis mediated by natural killer cells. Am. J. Pathol. 2005. 166: 443453.
  • 53
    Beziat, V., Hervier, B., Achour, A., Boutolleau, D., Marfain-Koka, A. and Vieillard, V., Human NKG2A overrides NKG2C effector functions to prevent autoreactivity of NK cells. Blood 2011. 117: 43944396.
  • 54
    Angelini, D. F., Zambello, R., Galandrini, R., Diamantini, A., Placido, R., Micucci, F., Poccia, F. et al., NKG2A inhibits NKG2C effector functions of gammadelta T cells: implications in health and disease. J. Leukoc. Biol. 2011. 89: 7584.
  • 55
    Bedossa, P. and Poynard, T., An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996. 24: 289293.
  • 56
    Bryceson, Y. T., Fauriat, C., Nunes, J. M., Wood, S. M., Bjorkstrom, N. K., Long, E. O. and Ljunggren, H. G., Functional analysis of human NK cells by flow cytometry. Methods Mol. Biol. 2010. 612: 335352.
  • 57
    Lee, N., Llano, M., Carretero, M., Ishitani, A., Navarro, F., Lopez-Botet, M. and Geraghty, D. E., HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc. Natl. Acad. Sci. USA 1998. 95: 51995204.
  • 58
    Roederer, M., Nozzi, J. L. and Nason, M. C., SPICE: exploration and analysis of post-cytometric complex multivariate datasets. Cytometry Part A: J. Intl. Soc. Anal. Cytol. 2011. 79: 167174.